GLP-1 medications are in the spotlight and dont seem to be slowing down any time soon
On the contrary, both GLP-1, the native agonist of GLP-1R, and Semaglutide, the FDA-approved GLP-1 analog, are 31-amino acid helical polypeptides
Um levantamento da Close Up International ilustra a velocidade dessa transio: at abril de 2025, a semaglutida (Ozempic e Wegovy) dominava amplamente, com 96,6% das vendas no Brasil
I have been using these products for a couple months and they are AMAZING
Economic Damages Economic damages are typically supported by documentation and expert testimony: Medical expenses : ER visits, hospitalizations, surgeries, ongoing care Lost wages : Time away from work due to illness or recovery Future earning capacity : Particularly relevant in cases involving chronic impairment Accurate calculation requires coordination between medical experts, life care planners, and forensic economists